The first pick would be in the pharma space, we are seeing quite good momentum here today, so pharma you can see Syngene which is giving you a good fresh breakout above 700 level so I think it is looking quite positive from current levels to test higher targets of 720, 725.
Valuations decent, but bond momentum still stronger than equity: Maneesh Dangi
Maneesh Dangi provides insights into current market turmoil, attributing it to US strategies aimed at weakening the dollar. He explains how this affects gold prices,